Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.

about

Antimicrobial, antimycobacterial and antibiofilm properties of Couroupita guianensis Aubl. fruit extract Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation

P2860

Q24633975-CAE08D04-15E6-4446-BBED-6E4206FE3C3C Q33355620-48002B34-E63B-49C9-8615-8E5ADAD18D99

P2860

Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.

Item

http://www.wikidata.org/entity/Q39884320

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Indirubin potentiates ciproflo ...... pump of Staphylococcus aureus.

@en

Indirubin potentiates ciproflo ...... pump of Staphylococcus aureus.

@nl

type

Item

label

Indirubin potentiates ciproflo ...... pump of Staphylococcus aureus.

@en

Indirubin potentiates ciproflo ...... pump of Staphylococcus aureus.

@nl

prefLabel

Indirubin potentiates ciproflo ...... pump of Staphylococcus aureus.

@en

Indirubin potentiates ciproflo ...... pump of Staphylococcus aureus.

@nl

P1476

Indirubin potentiates ciproflo ...... pump of Staphylococcus aureus.

@en

P2093

Ignacimuthu Savarimuthu

http://www.w3.org/2001/XMLSchema#string

Kannan Ponnusamy

http://www.w3.org/2001/XMLSchema#string

M Gabriel Paulraj

http://www.w3.org/2001/XMLSchema#string

Mohankumar Ramasamy

http://www.w3.org/2001/XMLSchema#string

P2860

Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine

Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.

The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective.

Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.

Bacterial efflux pump inhibitors from natural sources.

In vitro activity of the new quinolone WCK 771 against staphylococci.

Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853).

Inactivation of antibiotics and the dissemination of resistance genes.

The potential management of resistant infections with non-antibiotics.

Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance.

P304

500-505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00365541003713630

http://www.w3.org/2001/XMLSchema#string

P433

6-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20380543

http://www.w3.org/2001/XMLSchema#string

Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.

about

P2860

P2860

Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698